President makes push to bring down drug prices that have long been a source of financial strain for US patients.
President Donald Trump has signed an executive order aimed at reducing U.S. prescription drug prices by up to 90%, blaming high costs primarily on foreign nations while acknowledging the pharmaceutical industry’s role. He asserted that Americans should pay the same prices as Europeans, a stance criticized by Senator Bernie Sanders, who argued the issue lies with U.S. companies’ profits. The administration plans to communicate price targets to manufacturers, yet experts express skepticism about the effectiveness and timeline of these measures.
